Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hemostasis
MedTech
FDA clears Medtronic's powder-to-gel spray for upper GI bleeds
Studies have shown that the Nexpowder system leads to immediate hemostasis in at least 94% of cases of upper gastrointestinal bleeding.
Andrea Park
Sep 28, 2022 11:00am
FDA clears Werfen’s hemostasis testing system
Jul 18, 2022 11:13am
Stryker buys Gauss Surgical for its AI blood-measuring tech
Sep 8, 2021 11:08am
Surgical glue maker Tissium nets €50M to move into nerve repair
Aug 31, 2021 12:40pm
Hemab raises $55M to target multiple rare bleeding indications
Jul 22, 2021 3:00am
J&J, Takeda call off $400M bloodstopper patch deal
Apr 14, 2020 12:05pm